Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus

Keith D Robertson, Peter A. Jones

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

The INK4a/ARF locus on human chromosome 9p resides at the nexus of two critical cell cycle regulatory pathways, the p53 pathway and the retinoblastoma (pRb) gene pathway. Through the use of shared coding regions and alternative reading frames two distinct proteins are produced: INK4a is a cyclin-dependent kinase inhibitor whereas ARF binds the MDM2 protooncogene and stabilizes p53. We have examined the expression patterns of the INK4a/ARF locus at the RNA level in normal human and murine tissues to determine if these genes are coordinately regulated. We found that both INK4a and ARF were expressed in most tissues at low levels detectable only by RT-PCR. The pancreas was an exception in that it expressed no detectable ARF mRNA but expressed high levels of INK4a mRNA. Furthermore, human pancreas expressed an additional previously unrecognized splice variant of INK4a, termed p12, through the use of an alternative splice donor site within intron 1. The p12 transcript produced a 12 kD protein composed of INK4a exon 1x and a novel intron-derived C-terminus. This novel protein did not interact with cdk4 but was capable of suppressing growth in a pRb-dependent manner. The implications of the capacity of the INK4a/ARF locus to encode a third transcript, and for pancreatic cancer, in which the INK4a/ARF locus is nearly always altered, are considered.

Original languageEnglish (US)
Pages (from-to)3810-3820
Number of pages11
JournalOncogene
Volume18
Issue number26
DOIs
StatePublished - Jul 1 1999
Externally publishedYes

Fingerprint

Alternative Splicing
Cell Cycle
RNA Splice Sites
Introns
Pancreas
Retinoblastoma Genes
Reading Frames
Messenger RNA
Proteins
Cyclin-Dependent Kinases
Retinoblastoma
Human Chromosomes
Pancreatic Neoplasms
Exons
RNA
Polymerase Chain Reaction
Growth
Genes

Keywords

  • Alternative splicing
  • ARF
  • Expression patterns
  • INK4a
  • Pancreas

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. / Robertson, Keith D; Jones, Peter A.

In: Oncogene, Vol. 18, No. 26, 01.07.1999, p. 3810-3820.

Research output: Contribution to journalArticle

@article{45492c0e64054b2baedcc8cb22751af4,
title = "Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus",
abstract = "The INK4a/ARF locus on human chromosome 9p resides at the nexus of two critical cell cycle regulatory pathways, the p53 pathway and the retinoblastoma (pRb) gene pathway. Through the use of shared coding regions and alternative reading frames two distinct proteins are produced: INK4a is a cyclin-dependent kinase inhibitor whereas ARF binds the MDM2 protooncogene and stabilizes p53. We have examined the expression patterns of the INK4a/ARF locus at the RNA level in normal human and murine tissues to determine if these genes are coordinately regulated. We found that both INK4a and ARF were expressed in most tissues at low levels detectable only by RT-PCR. The pancreas was an exception in that it expressed no detectable ARF mRNA but expressed high levels of INK4a mRNA. Furthermore, human pancreas expressed an additional previously unrecognized splice variant of INK4a, termed p12, through the use of an alternative splice donor site within intron 1. The p12 transcript produced a 12 kD protein composed of INK4a exon 1x and a novel intron-derived C-terminus. This novel protein did not interact with cdk4 but was capable of suppressing growth in a pRb-dependent manner. The implications of the capacity of the INK4a/ARF locus to encode a third transcript, and for pancreatic cancer, in which the INK4a/ARF locus is nearly always altered, are considered.",
keywords = "Alternative splicing, ARF, Expression patterns, INK4a, Pancreas",
author = "Robertson, {Keith D} and Jones, {Peter A.}",
year = "1999",
month = "7",
day = "1",
doi = "10.1038/sj.onc.1202737",
language = "English (US)",
volume = "18",
pages = "3810--3820",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "26",

}

TY - JOUR

T1 - Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus

AU - Robertson, Keith D

AU - Jones, Peter A.

PY - 1999/7/1

Y1 - 1999/7/1

N2 - The INK4a/ARF locus on human chromosome 9p resides at the nexus of two critical cell cycle regulatory pathways, the p53 pathway and the retinoblastoma (pRb) gene pathway. Through the use of shared coding regions and alternative reading frames two distinct proteins are produced: INK4a is a cyclin-dependent kinase inhibitor whereas ARF binds the MDM2 protooncogene and stabilizes p53. We have examined the expression patterns of the INK4a/ARF locus at the RNA level in normal human and murine tissues to determine if these genes are coordinately regulated. We found that both INK4a and ARF were expressed in most tissues at low levels detectable only by RT-PCR. The pancreas was an exception in that it expressed no detectable ARF mRNA but expressed high levels of INK4a mRNA. Furthermore, human pancreas expressed an additional previously unrecognized splice variant of INK4a, termed p12, through the use of an alternative splice donor site within intron 1. The p12 transcript produced a 12 kD protein composed of INK4a exon 1x and a novel intron-derived C-terminus. This novel protein did not interact with cdk4 but was capable of suppressing growth in a pRb-dependent manner. The implications of the capacity of the INK4a/ARF locus to encode a third transcript, and for pancreatic cancer, in which the INK4a/ARF locus is nearly always altered, are considered.

AB - The INK4a/ARF locus on human chromosome 9p resides at the nexus of two critical cell cycle regulatory pathways, the p53 pathway and the retinoblastoma (pRb) gene pathway. Through the use of shared coding regions and alternative reading frames two distinct proteins are produced: INK4a is a cyclin-dependent kinase inhibitor whereas ARF binds the MDM2 protooncogene and stabilizes p53. We have examined the expression patterns of the INK4a/ARF locus at the RNA level in normal human and murine tissues to determine if these genes are coordinately regulated. We found that both INK4a and ARF were expressed in most tissues at low levels detectable only by RT-PCR. The pancreas was an exception in that it expressed no detectable ARF mRNA but expressed high levels of INK4a mRNA. Furthermore, human pancreas expressed an additional previously unrecognized splice variant of INK4a, termed p12, through the use of an alternative splice donor site within intron 1. The p12 transcript produced a 12 kD protein composed of INK4a exon 1x and a novel intron-derived C-terminus. This novel protein did not interact with cdk4 but was capable of suppressing growth in a pRb-dependent manner. The implications of the capacity of the INK4a/ARF locus to encode a third transcript, and for pancreatic cancer, in which the INK4a/ARF locus is nearly always altered, are considered.

KW - Alternative splicing

KW - ARF

KW - Expression patterns

KW - INK4a

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=0033166440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033166440&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1202737

DO - 10.1038/sj.onc.1202737

M3 - Article

C2 - 10445844

AN - SCOPUS:0033166440

VL - 18

SP - 3810

EP - 3820

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 26

ER -